Deals and Data

Deals and Data

Takeda subsidiary Millenium’s blood cancer drug, Velcade, approved for wider use in US; previously used for untreated patients with MCL. (Boston Globe, 10/09/14)

FDA grants priority review of Amgen’s immunotherapy treatment for adult patients with Ph- relapsed/refractory B-precursor acute lymphoblastic leukemia. (OncLive, 10/09/14)

Infants with severe spinal muscular atrophy show improvement in Phase 2 clinical trial of Isis Pharmaceuticals’ ISIS-SMNRx. (U-T San Diego, 10/10/14)

The Scripps Research Institute’s Andrew Su named co-director of new center to apply the growing torrent of “big data” to complex biological problems. (U-T San Diego, 10/10/14)

Scripps Research Institute’s Erica Ollmann Saphire seeks crowdfunding for better instruments to be used to study Ebola antibodies to find the best treatment. (U-T San Diego, 10/11/14)

FDA grants priority review of Pfizer’s palbociclib for use with letrozole in first-line treatment for postmenopausal women with ER-positive, HER-2-negative advanced breast cancer who have not received previous systemic treatment. (Healio, 10/13/14)

Sanofi’s investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea enters late-stage clinical trials. (Reuters, 10/14/14)

Quidel receives clearance to market its Lyra Adenovirus Assay, a real-time PCR test for the qualitative detection of human adenovirus viral DNA from nasal and nasopharyngeal swabs. (Genome Web, 10/14/14)

Astellas Pharma signs up Harvard Medical School researcher to investigate the degenerative eye disease Retinitis pigmentosa and help seek out new treatments to combat it. (PharmaTimes, 10/14/14)

Aethlon Medical’s Hemopurifier blood filtration device has been used on a Ugandan doctor with Ebola. (U-T San Diego, 10/14/14)

Thermo Fisher Scientific’s Ion PGM Dx System received CE-IVD mark; establishes high-performing next-generation clinical sequencing workflows. (Genome Web, 10/16/14)

Sanofi Pasteur teams up with Immune Design to develop a herpes simplex virus immune therapy. (GEN News, 10/16/14)

Thermo Fisher Scientific develops new mass spec workflow that combines the advantages of data-independent and data-dependent analyses. (Genome Web, 10/17/14)

Novartis’ study shows panobinostat has anti-myeloma activity when combined with bortezomib and dexamethasone. (Healio, 10/20/14)

Novartis extends multi-year research agreement covering use of Somalogic’s aptamer-based proteomics platform for drug development work. (Genome Web, 10/20/14)

Janssen’s Imbruvica gets green light for use in adults with relapsed or refractory mantle cell lymphoma or chronic lymphocytic leukaemia. (PM Live, 10/20/14)

FDA panel unanimously recommends use of Novartis’ anti-inflammation drug in patients with a type of psoriasis. (Reuters, 10/20/14)

Merck and Sanofi’s Biologics License Application accepted for pediatric hexavalent combination vaccine containing DTaP, inactivated poliovirus, Haemophilus influenzae type B and hepatitis B vaccines. (Healio, 10/21/14)

DexCom wins pre-market approval for its DexCom Share device, a wireless remote monitor designed to be connected with its G4 Platinum continuous glucose monitor. (Mass Device, 10/20/14)

Illumina and International Cowpea Consortium develop new SNP genotyping array for cowpea to aid in improving crop yield, particularly in West Africa, where the protein-rich legume is a dietary staple. (Genome Web, 10/21/14)

FDA advisory panel votes 13-2 to recommend expanding approval of Vertex Pharmaceutical’s cystic fibrosis drug, Kalydeco, to include wider range of patients. (Reuters, 10/21/14)

Eli Lilly and Boehringer Ingelheim’s empagliflozin/metformin fixed-dose combination to be reviewed as a potential treatment for patients with type II diabetes. (Pharma Times, 10/21/14)